© 1993 by Oxford University Press
Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis
Thomas J. Smith, Bruce E. Hillner, and Christopher E. Desch
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Oncology..Supportive Care
- Medicine..Health Care
- Oncology..Treatment Options for Colorectal Cancer
- Oncology..Treatment Options for Testicular Cancer
- Medicine..Hypertension, Therapy
- Oncology..Elderly Patient Issues
- Oncology..End-of-Life and Palliative Care
- Oncology..Pain and Pain Management
- Oncology..Prevention of Cancer
- Oncology..Treatment Costs
- Oncology..Quality of Life
- Oncology..Mortality and Morbidity
- Oncology..Tobacco and Smoking
- Oncology..Mammography
- Medicine..Palliative Care
- Oncology..Policy and Patient Care Issues for Colorectal Cancer
- Oncology..Policy and Patient Care Issues for Testicular Cancer
- Oncology..Aging and Cancer
- Oncology..Blood & Bone Marrow Transplantation
- Oncology..Policy and Patient Care Issues for Leukemia
- Oncology..Epidemiology
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Camidge, A. Walker, J. J Oliver, F. Nussey, S. Maxwell, D. Jodrell, and D. J Webb Prognosis without treatment as a modifier in health economic assessments BMJ, June 11, 2005; 330(7504): 1382 - 1384. [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Smith, P. S. Staats, T. Deer, L. J. Stearns, R. L. Rauck, R. L. Boortz-Marx, E. Buchser, E. Catala, D. A. Bryce, P. J. Coyne, et al. Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival J. Clin. Oncol., October 1, 2002; 20(19): 4040 - 4049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Esnaola, S. N. Lazarides, S. J. Mentzer, and K. M. Kuntz Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer J. Clin. Oncol., January 1, 2002; 20(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Llovet, X Mas, J J Aponte, J Fuster, M Navasa, E Christensen, J Rodes, and J Bruix Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation Gut, January 1, 2002; 50(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Gaynon, B. C. Bostrom, R. J. Hutchinson, B. J. Lange, J. B. Nachman, P. G. Steinherz, M. G. Sensel, M. K. Lee, D. O. Stram, and H. N. Sather Duration of Hospitalization as a Measure of Cost on Children's Cancer Group Acute Lymphoblastic Leukemia Studies J. Clin. Oncol., April 1, 2001; 19(7): 1916 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Smith, J. Girtman, and J. Riggins Why Academic Divisions of Hematology/Oncology Are in Trouble and Some Suggestions for Resolution J. Clin. Oncol., January 1, 2001; 19(1): 260 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Earle, R. H. Chapman, C. S. Baker, C. M. Bell, P. W. Stone, E. A. Sandberg, and P. J. Neumann Systematic Overview of Cost-Utility Assessments in Oncology J. Clin. Oncol., September 18, 2000; 18(18): 3302 - 3317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Abramson, M. P. Rosen, L. J. Perry, D. P. Brophy, S. L. Raeburn, and K. E. Stuart Cost-effectiveness of Hepatic Arterial Chemoembolization for Colorectal Liver Metastases Refractory to Systemic Chemotherapy Radiology, August 1, 2000; 216(2): 485 - 491. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. M. Remer, N. Obuchowski, J. D. Ellis, T. W. Rice, D. J. Adelstein, and M. E. Baker Adrenal Mass Evaluation in Patients with Lung Carcinoma: A Cost-Effectiveness Analysis Am. J. Roentgenol., April 1, 2000; 174(4): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Smith and B. E. Hillner Tamoxifen Should be Cost-Effective in Reducing Breast Cancer Risk in High-Risk Women J. Clin. Oncol., January 14, 2000; 18(2): 284 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Hillner, J. C. Weeks, C. E. Desch, and T. J. Smith Pamidronate in Prevention of Bone Complications in Metastatic Breast Cancer: A Cost-Effectiveness Analysis J. Clin. Oncol., January 1, 2000; 18(1): 72 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Friedberg, B. Saffran, T. J. Stinson, W. Nelson, and C. L. Bennett Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology JAMA, October 20, 1999; 282(15): 1453 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lee, C. Anasetti, K. M. Kuntz, J. Patten, J. H. Antin, and J. C. Weeks The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia Blood, December 1, 1998; 92(11): 4047 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook J Natl Cancer Inst Monographs, August 1, 1998; 1998(24): 1 - 28. [Full Text]
|
|
|
|
 |
|
 J.-P. Droz, S. Culine, P. Biron, and A. Kramar High-Dose Chemotherapy in Adult Solid Tumors and Lymphoproliferative Disorders: The Need for Randomized Trials Oncologist, April 1, 1997; 2(2): 83 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Freedberg, W. D. Hardy, R. S. Holzman, A. N.A. Tosteson, and D. E. Craven Validating Literature-based Models with Direct Clinical Trial Results: The Cost-Effectiveness of Secondary Prophylaxis for PCP in AIDS Patients Med Decis Making, February 1, 1996; 16(1): 29 - 35. [Abstract] [PDF]
|
|
|
|
 |
|
 D. M. Ota Laparoscopic Management of Colon Cancer Surgical Innovation, March 1, 1994; 1(1): 18 - 25. [Abstract] [PDF]
|
|
|
|
|
|
T. J. Smith Which Hat Do I Wear? JAMA, October 13, 1993; 270(14): 1657 - 1659. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||